Glenmark Re-Evaluates Complex Generics Basket, Won’t Be Part Of The 'Crowd'

 
• By Anju Ghangurde
Pros & Cons
GLENMARK HAS DISCONTINUED DEVELOPMENT OF CERTAIN COMPLEX GENERICS

More from India

More from Focus On Asia